Arjun Jj Desai - 12 Jun 2025 Form 4 Insider Report for TriSalus Life Sciences, Inc. (TLSI)

Reporting relationship: Director
Issuer ticker: TLSI
Reported as of: 12 Jun 2025
Net transaction value: $0
SEC form: 4
Accepted by SEC: 27 Jun 2025, 16:29:54 UTC
Prior SEC filing: 23 May 2025
Next SEC filing: 15 Aug 2025
Source filing: View source filing
Reporting owner signature: /s/ Mary Szela, Attorney-in-Fact

Key filing fact

Arjun Jj Desai filed Form 4 for TriSalus Life Sciences, Inc. (TLSI) on 27 Jun 2025.

Key facts

This page summarizes Arjun Jj Desai's Form 4 filing for TriSalus Life Sciences, Inc. (TLSI).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 27 Jun 2025, 16:29.

Change

Previous filing in this sequence was filed on 23 May 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001982985 Primary reporting owner

Desai Arjun JJ

Relationship: Director
Address: 6272 W. 91ST AVENUE, WESTMINSTER
Signature: /s/ Mary Szela, Attorney-in-Fact
Signature date: 27 Jun 2025

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

TLSI transaction Derivative

Director Stock Option (right to buy)

Award

Transaction value: $0
Shares: +15,000
Change %: +30%
Price: $0.000000
Shares after: 65,000
Date: 12 Jun 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 15,000
Exercise price: $5.50
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The shares subject to the option shall fully vest on the one-year anniversary of the grant date of June 12, 2025, provided that the shares subject to the option will in any case be fully vested on the date of the Issuer's next annual stockholder meeting, subject to the Reporting Person's continued service with the Issuer.